While previous research primarily focused on T2D or obesity-specific populations, our study specifically examines therapeutic implications for MASLD patients, addressing a critical knowledge gap regarding the benefits of combination therapy on various clinical endpoints including all-cause hospitalization, all-cause mortality, MAKE, and MALO in this population
only the branding, approval indication, and sometimes pricing differ
We potentially have a fourth pillar for preventing progression of chronic kidney disease with significant cardiovascular benefits
Treatment depends on the severity of the condition
Theyre willing to work for you and fight for you. Having that support, and Triple Therapy, made all the difference in the world for her
Hospitalization is often required for these cases, and treatment may later transition to oral antibiotics